Rus Eng

Project underdevelopment

Advantages of biosimilars:
  • low variability (more stable effect);
  • cost efficiency.

Name of
the drug
Stage:
Pharmaceut. Development
Preclinical Trials
Clinical Trials
Stage I
Stage II
Stage III
registration
Insulin human biphasic (recombinant) GP40031
Insulin aspart GP40071
Insulin aspart biphasic GP40081
Insulin degludec GP40131
GP40201
GP40191
GP40211
Biosimilar
Original drug
Generic

Project underdevelopment

Name of
the drug
Stage:
Pharmaceut. Development
Preclinical Trials
Clinical Trials
Stage I
Stage II
Stage III
registration
Evogliptin + Metformin GP10021
GP30091
GP30111
GP30151
GP30211
GP40141
GP30201
GP30221
GP30231

You are a health care professional?

Go up